• English
  • 简体中文
Login Register
Current Location: Home > CFDA Approvals(Domestic) Feedback Help
Latest Data
-
-
-
Historical Data
-
-
-
-
-
Export
Drug Name Active Ingredient Dosage Form Strength Manufacturers Manufacturers Approval No. Same Variety(Same Strength) Approval Date Drug Classification Details
米氮平片 mirtazapine Tablet 15mg 哈尔滨三联药业股份有限公司 Harbin Medisan Pharmaceutical Co Ltd 国药准字H20060702 view 2021-06-21 Medicare(class A) view
米氮平片 mirtazapine Tablet 30mg 华裕(无锡)制药有限公司 HUA-YU (WUXI) Pharmaceutical Co Ltd 国药准字H20041656 view 2020-06-24 Medicare(class A) view
米氮平片 mirtazapine Tablet 15mg 华裕(无锡)制药有限公司 HUA-YU (WUXI) Pharmaceutical Co Ltd 国药准字H20100103 view 2020-06-24 Medicare(class A) view
米氮平片 mirtazapine Tablet 15mg 山西康宝生物制品股份有限公司 Shanxi Kangbao Biological Product Co Ltd 国药准字H20080101 view 2018-01-09 Medicare(class A) view
米氮平片 mirtazapine Tablet 30mg 哈尔滨三联药业股份有限公司 Harbin Medisan Pharmaceutical Co Ltd 国药准字H20184125 view 2021-06-21 Medicare(class A) view